Study Protocol and Baseline Characteristics of Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid: RESPECT-EPA, the Combination of a Randomized Control Trial and an Observational Biomarker Study